
Warning letters, 483s, Recalls, Import Alerts, Audit observations
Indian drug regulatory, CDSCO has notified the new online Export NOC system for Unapproved Drugs / Unapproved New Drugs. As per the new system application for Export NOC shall be submitted online through CDSCOs Sugam portal @ https://cdscoonline.gov.in/. CDSCO has issued new guidance document with templates for documents to be submitted for export NOC applications through the Sugam portal.
Manufacturers holding valid license in Form 25, Form 28 or Form 28D can obtain No Objection Certificates (NOCs) for manufacture of Unapproved Drugs / Approved New Drugs for Export purposes from Zonal offices of the CDSCO
Easing of Compliance Burden
With the new Export NOC system, Quantity-Specific and Purchase Order (PO)-Specific NOCs have been discontinued. Instead, Export NOCs will now be issued with a one-year validity from the date of registration. The new system also allows unused quantities from previous export orders to be utilized for subsequent orders. Under the new system, Export NOCs will be processed within seven working days from registration.
According to the CDSCO notification, these changes aim to reduce the compliance burden on applicants and streamline the process.
Application Process
Applicants must complete a one-time registration through the Integrated Registration Form (IRF) and submit the following documents:
Export Process
When exporting the drug, the applicant must submit relevant documents via the online portal for release of consignment clearance at the port. Required documents include:
The port office will verify these documents before clearing the consignment.
The new Export NOC system replaces the older process where companies had to submit applications along with purchase orders (POs), and NOCs were issued only for specific POs and quantities. The updated process offers greater flexibility, reduces delays, and simplifies compliance for exporters.
CDSCO Notification and Guidance for New Online System for Export NOC (March 2025)
Leave a Comment
You must be logged in to post a comment.